EUVIMEDEUVIMED entdecken
Leserbrief

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

Rena Buckstein iD, Jeannie Callum, Anca Prica, David Bowen, Richard A Wells, Brian Leber, Nancy Heddle, Lisa Chodirker, Matthew Cheung iD, Lee Mozessohn iD, Karen Yee, Jennifer Gallagher und 9 weitere

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27181 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Rena Buckstein und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Outpatients. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Canadian Cancer Society Research Institute, NHSBT R&D, the Australian and New Zealand Society of Blood Transfusions (ANZSBT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesOutpatientsHumansErythrocyte TransfusionFeasibility StudiesRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, Kingston Health Sciences Center, Kingston, Ontario, Canada.
  • Department of Medicine, Princess Margaret Hospital, United Health Network, Toronto, Ontario, Canada.
  • Department of Medicine, University of York, York, UK.
  • Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada.
  • Mcmaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Rena Buckstein, Matthew Cheung, Lee Mozessohn, Zoe McQuilten

Förderung

  • Canadian Cancer Society Research Institute
  • NHSBT R&D
  • the Australian and New Zealand Society of Blood Transfusions (ANZSBT)
  • the Wellington Division of New Zealand Cancer Society
  • MOSPI Fund
  • Australian and New Zealand Society of Blood Transfusion

Zitieren

APA

Buckstein, R., Callum, J., Prica, A., Bowen, D., Wells, R. A., Leber, B., Heddle, N., Chodirker, L., Cheung, M., Mozessohn, L., Yee, K., Gallagher, J., Parmentier, A., Jamula, E., McQuilten, Z., Wood, E. M., Weinkov, R., Zhang, L., Mamedov, A., …, & Lin, Y. (2024). Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies. American Journal of Hematology. https://doi.org/10.1002/ajh.27181

Vancouver

Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, et al. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies. American Journal of Hematology. 2024. doi:10.1002/ajh.27181

BibTeX
@article{Buckstein2024,
  author = {Buckstein, Rena and Callum, Jeannie and Prica, Anca and Bowen, David and Wells, Richard A and Leber, Brian and Heddle, Nancy and Chodirker, Lisa and Cheung, Matthew and Mozessohn, Lee and Yee, Karen and Gallagher, Jennifer and Parmentier, Anne and Jamula, Erin and McQuilten, Zoe and Wood, Erica M and Weinkov, Robert and Zhang, Liying and Mamedov, Alex and Stanworth, Simon J and Lin, Yulia},
  title = {Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27181}
}
Kostenlos starten →